Skip to content
Product
Resources
Downloads & Videos
Publications
Science
Applications
Cell Therapy
Disease Profiling
Drug Discovery
Company
Our Mission
Our Team
News
Careers
Partner with Us
Distributors
Conferences
Menu
Contact
Linkdin
Menu
Product
Resources
Downloads & Videos
Publications
Science
Applications
Cell Therapy
Disease Profiling
Drug Discovery
Company
Our Mission
Our Team
News
Careers
Partner with Us
Distributors
Conferences
Menu
Contact
Linkdin
日本語
News
Events
News
All
News
ThinkCyte Unveils MorphoScan Cloud: A Versatile Cloud-Based Platform for AI-Driven Cell Morphology Data Analysis
Jun 3, 2025
read
News
ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research
Jan 29, 2025
read
Events
Sponsored Webinar: Cell Therapies for Cancer Treatment
Nov 13, 2024
read
Events
VisionSort on Display at BioJapan 2024
Sep 25, 2024
read
Events
ThinkCyte Showcases VisionSort for Drug Discovery at ELRIG 2024
Sep 25, 2024
read
News
New Publication Highlights Ghost Cytometry for Quality Control in Cell Therapy Manufacturing
Sep 19, 2024
read
News
ThinkCyte Secures $32 million in Series C Funding to Drive Global Expansion of VisionSort™
Aug 29, 2024
read
Events
ThinkCyte to Attend the 34th Annual Conference of the German Society for Cytometry
Aug 13, 2024
read
Events
ThinkCyte to Showcase VisionSort at GLIIFCA’s 33rd Annual Meeting
Jul 29, 2024
read
News
ThinkCyte Launches New Website and Showcases VisionSort at Global Events
May 16, 2024
read
Events
ThinkCyte to Exhibit at ARVO 2024
Apr 29, 2024
read
Events
ThinkCyte to Exhibit at AAI 2024
Apr 29, 2024
read
Events
ThinkCyte to Showcase VisionSort at CYTO 2024
Apr 5, 2024
read
News
ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones
Apr 1, 2024
read
Events
ThinkCyte to Attend the 2024 Association of Biomolecular Resource Facilities (ABRF) Annual Meeting
Mar 28, 2024
read
Events
ThinkCyte to Attend SoCal Flow SUMMIT 2024
Mar 28, 2024
read
Events
ThinkCyte to Showcase VisionSort at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Mar 28, 2024
read
News
ThinkCyte collaborates with joint research group to advance development of stem cell-based therapies
Jan 23, 2024
read
Events
ThinkCyte to Present VisionSort Applications in Drug Screening at the 2024 Society for Laboratory Automation and Screening (SLAS) Annual Meeting
Jan 19, 2024
read
News
ThinkCyte Launches Partnering Platform
Jan 9, 2024
read
News
ThinkCyte Secures $24 million in Funding to Accelerate Growth
Nov 28, 2023
read
News
ThinkCyte and FIMM Establish Research Partnership to Advance Understanding and Treatment of Blood Cancer
Jul 17, 2023
read
News
Juntendo University, Sysmex, and ThinkCyte collaborate to advance the early detection and treatment of blood cancer
Apr 17, 2023
read
News
ThinkCyte primed for continued growth as it expands with new Bay Area headquarters
Apr 10, 2023
read
Events
ThinkCyte to Showcase VisionSort at the 2023 American Association for Cancer Research (AACR) Annual Meeting
Apr 6, 2023
read
News
ThinkCyte reveals VisionSort™, the world’s first dual mode, AI-driven cell characterization and sorting platform.
Mar 3, 2023
read
Events
ThinkCyte to Debut VisionSort at the 2023 Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition
Feb 13, 2023
read
News
ThinkCyte broadens Advisory Board with the appointments of Dr. Diether Recktenwald, Ph.D. and Dr. Bo Saxberg, M.D. Ph.D.
Jan 23, 2023
read
News
ThinkCyte and Axcelead DDP collaborate to advance novel phenotypic drug screening methods
Dec 26, 2022
read
News
PhoreMost and ThinkCyte collaborate to advance AI-based drug discovery
Dec 13, 2022
read
Events
ThinkCyte to Showcase Ghost Cytometry at the 64th ASH Annual Meeting and Exposition
Dec 6, 2022
read
News
Vision Care Group and ThinkCyte Announce Research Alliance in Advanced Cell Therapy
Dec 6, 2022
read
News
ThinkCyte announces Premier Early Access Program for its new label-free cell characterization and sorting system
Jul 21, 2022
read
News
ThinkCyte shares applications of Ghost Cytometry with industrial and academic thought leaders
Jul 11, 2022
read
News
ThinkCyte’s novel label-free in-silico ghost cytometry published in eLife
Dec 21, 2021
read
News
ThinkCyte Secures $26 Million in Series B Financing
May 19, 2021
read
News
Sysmex and ThinkCyte Agree on Joint Development and Capital Alliance
May 12, 2021
read
News
ThinkCyte Awarded NEDO PCA Grant to Advance Label-free Cell Sorting Technology for Cell Therapy
Aug 24, 2020
read
News
ThinkCyte and National Cancer Center Japan Jointly Awarded AMED Grant for Isolation of Circulating Tumor Cells
Jul 9, 2020
read
News
Hitachi and ThinkCyte Announce Collaboration to Develop an AI-driven Cell Analysis and Sorting System
Jul 1, 2020
read
News
ThinkCyte Completes $15 Million Series A Financing
May 29, 2020
read
News
ThinkCyte Selected for J-Startup Program
Jun 24, 2019
read
News
ThinkCyte Graduated Berkeley SkyDeck Cohort Program
Dec 20, 2018
read
News
ThinkCyte Selected for the Inaugural Class of Google Launchpad Accelerator Tokyo
Nov 1, 2018
read
News
ThinkCyte Publishes Paper on “Ghost Cytometry” Method in Science
Jun 15, 2018
read
News
ThinkCyte Completes Seed Financing
Jun 15, 2018
read
